Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Sep;44(3):467–471. doi: 10.1038/bjc.1981.208

Antagonism of drugs used in leukaemia therapy to the killing of human lymphoblastoid cells by steroid.

R M Gledhill, M R Norman
PMCID: PMC2010763  PMID: 6945118

Full text

PDF
467

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertino J. R. Toward improved selectivity in cancer chemotherapy: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1979 Feb;39(2 Pt 1):293–304. [PubMed] [Google Scholar]
  2. Chabner B. A., Myers C. E., Coleman C. N., Johns D. G. The clinical pharmacology of antineoplastic agents (first of two parts). N Engl J Med. 1975 May 22;292(21):1107–1113. doi: 10.1056/NEJM197505222922107. [DOI] [PubMed] [Google Scholar]
  3. FOLEY G. E., LAZARUS H., FARBER S., UZMAN B. G., BOONE B. A., MCCARTHY R. E. CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. Cancer. 1965 Apr;18:522–529. doi: 10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  4. Goldman I. D., Lichtenstein N. S., Oliverio V. T. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. J Biol Chem. 1968 Oct 10;243(19):5007–5017. [PubMed] [Google Scholar]
  5. Graham F. L., Whitmore G. F. The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells. Cancer Res. 1970 Nov;30(11):2627–2635. [PubMed] [Google Scholar]
  6. Harmon J. M., Norman M. R., Fowlkes B. J., Thompson E. B. Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line. J Cell Physiol. 1979 Feb;98(2):267–278. doi: 10.1002/jcp.1040980203. [DOI] [PubMed] [Google Scholar]
  7. Jones P. A., Baker M. S., Benedict W. F. The effect of 1-beta-D-arabinofuranosylcytosine on cell viability, DNA synthesis, and chromatid breakage in synchronized hamster fibrosarcoma cells. Cancer Res. 1976 Oct;36(10):3789–3797. [PubMed] [Google Scholar]
  8. Kufe D. W., Major P. P., Egan E. M., Beardsley G. P. Correlation of cytotoxicity with incorporation of ara-C into DNA. J Biol Chem. 1980 Oct 10;255(19):8997–8900. [PubMed] [Google Scholar]
  9. Nelson J. A., Carpenter J. W., Rose L. M., Adamson D. J. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine. Cancer Res. 1975 Oct;35(10):2872–2878. [PubMed] [Google Scholar]
  10. Norman M. R., Harmon J. M., Thompson E. B. Use of a human lymphoid cell line to evaluate interactions between prednisolone and other chemotherapeutic agents. Cancer Res. 1978 Nov;38(11 Pt 2):4273–4278. [PubMed] [Google Scholar]
  11. Norman M. R., Thompson E. B. Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res. 1977 Oct;37(10):3785–3791. [PubMed] [Google Scholar]
  12. Tidd D. M., Paterson A. R. Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res. 1974 Apr;34(4):733–737. [PubMed] [Google Scholar]
  13. Weizsaecker M., Deen D. F. Effect of feeder cell-released substances on the survival of clonogenic 9L cells after treatment with antimetabolites. Cancer Res. 1980 Sep;40(9):3202–3205. [PubMed] [Google Scholar]
  14. Woodcock D. M., Fox R. M., Cooper I. A. Evidence for a new mechanism of cytotoxicity of 1-beta-D arabinofuranosylcytosine. Cancer Res. 1979 Apr;39(4):1418–1424. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES